VEGFA and myalgic encephalomeyelitis/chronic fatigue syndrome: MiR-374b-5p targets vascular endothelial growth factor A (VEGFA), involved in vasculogenesis and angiogenesis, which regulate the capillary supply in skeletal muscle and thereby may be linked to the post-exertional malaise and fatigue seen in patients with ME/CFS and FM [121].